Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.
Noxopharm (ASX:NOX)
Noxopharm passed its final in vivo preclinical safety study for its SOF-SKN drug candidate for autoimmune diseases, with no issues identified, ahead of regulatory submission for the Heracles clinical trial.
Great Western Exploration (ASX:GTE)
Great Western Exploration completed its maiden drilling program at the Sumo niobium target, located within its Yerrida North project in Western Australia.
Swift Networks Group (ASX:SW1)
Swift Networks Group extended the closing date of its entitlement offer by two weeks to May 6, following "significant" global stock market volatility and shareholder requests. The extension allows additional time to receive the entitlement offer material and evaluate the opportunity.
Rincon Resources (ASX:RCR)
Rincon Resources completed a site visit to its Laverton gold project in Western Australia and is now preparing for its first drilling on-ground since 2021.
Aurumin (ASX:AUN)
Aurumin completed reverse circulation drilling at its Johnson Range project, part of the Sandstone gold project in Western Australia. Samples have been finalized and are being transported to the laboratory, with results expected in May.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.